Evidence map›Paper›PMID 23793365›Full record

ArticleDer Pathologe2013

[Breast cancer: current recommendations for pathologists on the basis of the S3 guidelines].

A Lebeau, H Kreipe, M Dietel, W Schlake, R Kreienberg

Abstract readEnglish Abstract
PubMed Publisher
In one paragraph

Article in Der Pathologe, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

A LebeauInstitut für Pathologie, Universitätsklinikum Hamburg-Eppendorf, Martinistrasse 52, Hamburg, Germany. a.lebeau@uke.de
H Kreipe
M Dietel
W Schlake
R Kreienberg

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Optimal management of breast cancer patients is based on efficient multidisciplinary cooperation. The role of pathologists is to survey those parameters that are crucial for the individually adopted therapy. Thereby, distinct quality criteria have to be considered concerning the handling of the tissue samples, including preparation and examination, as well as the analytical methods used. The interdisciplinary S3 guideline "Diagnosis, therapy and follow-up of breast cancer" includes recommendations concerning these aspects based on current evidence. Its third edition was published in July 2012. In this article an overview of the topics relevant for pathologists that have been modified in the latest edition is provided.

Indexed as

Guideline AdherenceBreastBreast NeoplasmsCarcinoma, DuctalCarcinoma, Intraductal, NoninfiltratingCooperative BehaviorEvidence-Based MedicineFemaleGene Expression ProfilingHumansInterdisciplinary CommunicationKi-67 AntigenLymphatic MetastasisMastectomyNeoplasm InvasivenessNeoplasm, ResidualKi-67 Antigen

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.